Reply to: "Comment on 'Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing,' by Dr Rosenthal et al"

Affiliations

Comment

Eric T Rosenthal. J Am Coll Radiol. 2017 May.

. 2017 May;14(5):582-584.

doi: 10.1016/j.jacr.2017.02.051.

¹ Myriad Genetic Laboratories, Inc, 320 Wakara Way, Salt Lake City, UT 84108. Electronic address: erosenth@myriad.com.

No abstract available

Comment on

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.
Rosenthal ET, Evans B, Kidd J, Brown K, Gorringe H, van Orman M, Manley S. Rosenthal ET, et al. J Am Coll Radiol. 2017 Apr;14(4):561-568. doi: 10.1016/j.jacr.2016.10.003. Epub 2016 Dec 20. J Am Coll Radiol. 2017. PMID: 28011157
Comment on "Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing".
van Marcke C, Vikkula M, Duhoux FP. van Marcke C, et al. J Am Coll Radiol. 2017 May;14(5):582. doi: 10.1016/j.jacr.2017.01.017. J Am Coll Radiol. 2017. PMID: 28473152 No abstract available.